Skip to main content


Figure 10 | BMC Medical Research Methodology

Figure 10

From: Improved curve fits to summary survival data: application to economic evaluation of health technologies

Figure 10

Curve fits to progression free survival for (a) sunitinib, (b) interferon-alpha for renal cell carcinoma. Kaplan-Meier graphs are represented by continuous stepped lines joined by dots, curves fit by the proposed method are shown by thick continuous lines, fits used in the original economic evaluation by thin continuous lines, and curves fit by least squares by dotted lines. In (b) the last two curves are almost coincident.

Back to article page